Quantitative ChIP-Seq normalization reveals global modulation of the epigenome

Cell Reports

Volumn 9, Issue 3, 2014, Pages 1163-1170

  Orlando, David A ^a   Chen, Mei Wei ^a   Brown, Victoria E ^a   Solanki, Snehakumari ^a   Choi, Yoon J ^a   Olson, Eric R ^a   Fritz, Christian C ^a   Bradner, James E ^b,c   Guenther, Matthew G ^a  

^a Syros Pharmaceuticals   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL POPULATION; CELL VIABILITY; CHIP WITH REFERENCE EXOGENOUS GENOME; CHROMATIN IMMUNOPRECIPITATION COUPLED WITH MASSIVELY PARALLEL DNA SEQUENCING; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA MODIFICATION; DNA SEQUENCE; EPIGENETICS; GENE EXPRESSION PROFILING; GENETIC PROCEDURES; GENOME; HISTONE MODIFICATION; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; ANIMAL; CHROMATIN IMMUNOPRECIPITATION; DROSOPHILA MELANOGASTER; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; HIGH THROUGHPUT SEQUENCING; JURKAT CELL LINE; METABOLISM; METHYLATION; PROCEDURES; STANDARD; STANDARDS;

MAMMALIA;

BENZIMIDAZOLE DERIVATIVE; EPZ-5676; HISTONE; LYSINE;

ANIMALS; BENZIMIDAZOLES; CHROMATIN IMMUNOPRECIPITATION; DROSOPHILA MELANOGASTER; EPIGENESIS, GENETIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTONES; HUMANS; JURKAT CELLS; LYSINE; METHYLATION; REFERENCE STANDARDS;

EID: 84919716184     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.10.018     Document Type: Article

References (41)

1. Azad, N., Zahnow, C.A., Rudin, C.M., and Baylin, S.B. (2013). The future of epigenetic therapy in solid tumours-lessons from the past. Nat Rev Clin Oncol 10, 256-266.
2. Badeaux, A.I., and Shi, Y. (2013). Emerging roles for chromatin as a signal integration and storage platform. Nat. Rev. Mol. Cell Biol. 14, 211-224.
3. Bardet, A.F., He, Q., Zeitlinger, J., and Stark, A. (2012). A computational pipeline for comparative ChIP-seq analyses. Nat. Protoc. 7, 45-61.
4. Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I., and Zhao, K. (2007). High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837.
5. Bonhoure, N., Bounova, G., Bernasconi, D., Praz, V., Lammers, F., Canella, D., Willis, I.M., Herr, W., Hernandez, N., and Delorenzi, M.; CycliX Consortium (2014). Quantifying ChIP-seq data: a spiking method providing an internal reference for sample-to-sample normalization. Genome Res. 24, 1157-1168.
6. Calo, E., and Wysocka, J. (2013). Modification of enhancer chromatin: what, how, and why? Mol. Cell 49, 825-837.
7. Daigle, S.R., Olhava, E.J., Therkelsen, C.A., Majer, C.R., Sneeringer, C.J., Song, J., Johnston, L.D., Scott, M.P., Smith, J.J., Xiao, Y., et al. (2011). Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 20, 53-65.
8. Daigle, S.R., Olhava, E.J., Therkelsen, C.A., Basavapathruni, A., Jin, L., Boriack-Sjodin, P.A., Allain, C.J., Klaus, C.R., Raimondi, A., Scott, M.P., et al. (2013). Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood 122, 1017-1025.
9. Dawson, M.A., and Kouzarides, T. (2012). Cancer epigenetics: from mechanism to therapy. Cell 150, 12-27.
10. Deshpande, A.J., Bradner, J., and Armstrong, S.A. (2012). Chromatin modifications as therapeutic targets in MLL-rearranged leukemia. Trends Immunol. 33, 563-570.
11. Guenther, M.G., Lawton, L.N., Rozovskaia, T., Frampton, G.M., Levine, S.S., Volkert, T.L., Croce, C.M., Nakamura, T., Canaani, E., and Young, R.A. (2008). Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev. 22, 3403-3408.
12. Jiang, L., Schlesinger, F., Davis, C.A., Zhang, Y., Li, R., Salit, M., Gingeras, T.R., and Oliver, B. (2011). Synthetic spike-in standards for RNA-seq experiments. Genome Res. 21, 1543-1551.
13. Kanno, J., Aisaki, K.I., Igarashi, K., Nakatsu, N., Ono, A., Kodama, Y., and Nagao, T. (2006). "Per cell" normalization method for mRNA measurement by quantitative PCR and microarrays. BMC Genomics 7, 64.
14. Kidder, B.L., Hu, G., and Zhao, K. (2011). ChIP-Seq: technical considerations for obtaining high-quality data. Nat. Immunol. 12, 918-922.
15. Krueger, F., Kreck, B., Franke, A., and Andrews, S.R. (2012). DNA methylome analysis using short bisulfite sequencing data. Nat. Methods 9, 145-151.
16. Landt, S.G., Marinov, G.K., Kundaje, A., Kheradpour, P., Pauli, F., Batzoglou, S., Bernstein, B.E., Bickel, P., Brown, J.B., Cayting, P., et al. (2012). ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 22, 1813-1831.
17. Lee, T.I., and Young, R.A. (2013). Transcriptional regulation and its misregulation in disease. Cell 152, 1237-1251.
18. Li, Y., Wang, H., Muffat, J., Cheng, A.W., Orlando, D.A., Lovén, J., Kwok, S.-M., Feldman, D.A., Bateup, H.S., Gao, Q., et al. (2013). Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13, 446-458.
19. Liang, K., and Kelesx, S. (2012). Normalization of ChIP-seq data with control. BMC Bioinformatics 13, 199.
20. Lin, C.Y., Lovén, J., Rahl, P.B., Paranal, R.M., Burge, C.B., Bradner, J.E., Lee, T.I., and Young, R.A. (2012). Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56-67.
21. Liu, B., Yi, J., Sv, A., Lan, X., Ma, Y., Huang, T.H., Leone, G., and Jin, V.X. (2013). QChIPat: a quantitative method to identify distinct binding patterns for two biological ChIP-seq samples in different experimental conditions. BMC Genomics 14 (Suppl 8), S3.
22. Lovén, J., Orlando, D.A., Sigova, A.A., Lin, C.Y., Rahl, P.B., Burge, C.B., Levens, D.L., Lee, T.I., and Young, R.A. (2012). Revisiting global gene expression analysis. Cell 151, 476-482.
23. Meyer, C.A., and Liu, X.S. (2014). Identifying and mitigating bias in nextgeneration sequencing methods for chromatin biology. Nat. Rev. Genet. 15, 709-721.
24. Nair, N.U., Sahu, A.D., Bucher, P., and Moret, B.M.E. (2012). ChIPnorm: a statistical method for normalizing and identifying differential regions in histone modification ChIP-seq libraries. PLoS ONE 7, e39573.
25. Ng, H.H., Feng, Q., Wang, H., Erdjument-Bromage, H., Tempst, P., Zhang, Y., and Struhl, K. (2002). Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association. Genes Dev. 16, 1518-1527.
26. Pastor, W.A., Aravind, L., and Rao, A. (2013). TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 14, 341-356.
27. Raha, D., Hong, M., and Snyder, M. (2010). ChIP-Seq: a method for global identification of regulatory elements in the genome. Curr. Protoc. Mol. Biol. Chapter 21, 1-14.
28. Rinn, J.L., and Chang, H.Y. (2012). Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145-166.
29. Rivera, C.M., and Ren, B. (2013). Mapping human epigenomes. Cell 155, 39-55.
30. Schübeler, D., Macalpine, D.M., Scalzo, D., Wirbelauer, C., Kooperberg, C., van Leeuwen, F., Gottschling, D.E., O'Neill, L.P., Turner, B.M., Delrow, J., et al. (2004). The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 18, 1263-1271.
31. Shanower, G.A., Muller, M., Blanton, J.L., Honti, V., Gyurkovics, H., and Schedl, P. (2005). Characterization of the grappa gene, the Drosophila histone H3 lysine 79 methyltransferase. Genetics 169, 173-184.
32. Steger, D.J., Lefterova, M.I., Ying, L., Stonestrom, A.J., Schupp, M., Zhuo, D., Vakoc, A.L., Kim, J.-E., Chen, J., Lazar, M.A., et al. (2008). DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol. Cell. Biol. 28, 2825-2839.
33. Sullivan, S., Sink, D.W., Trout, K.L., Makalowska, I., Taylor, P.M., Baxevanis, A.D., and Landsman, D. (2002). The Histone Database. Nucleic Acids Res. 30, 341-342.
34. Tan, M., Luo, H., Lee, S., Jin, F., Yang, J.S., Montellier, E., Buchou, T., Cheng, Z., Rousseaux, S., Rajagopal, N., et al. (2011). Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146, 1016-1028.
35. Tian, Z., Tolić, N., Zhao, R., Moore, R.J., Hengel, S.M., Robinson, E.W., Stenoien, D.L., Wu, S., Smith, R.D., and Paša-Tolić, L. (2012). Enhanced topdown characterization of histone post-translational modifications. Genome Biol. 13, R86.
36. van Bakel, H., and Holstege, F.C.P. (2004). In control: systematic assessment of microarray performance. EMBO Rep. 5, 964-969.
37. van de Peppel, J., Kemmeren, P., van Bakel, H., Radonjic, M., van Leenen, D., and Holstege, F.C.P. (2003). Monitoring global messenger RNA changes in externally controlled microarray experiments. EMBO Rep. 4, 387-393.
38. van Leeuwen, F., Gafken, P.R., and Gottschling, D.E. (2002). Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 109, 745-756.
39. Wee, S., Dhanak, D., Li, H., Armstrong, S.A., Copeland, R.A., Sims, R., Baylin, S.B., Liu, X.S., and Schweizer, L. (2014). Targeting epigenetic regulators for cancer therapy. Ann. N Y Acad. Sci. 1309, 30-36.
40. Wolffe, A.P., and Pruss, D. (1996). Hanging on to histones. Chromatin. Curr. Biol. 6, 234-237.
41. Zhou, V.W., Goren, A., and Bernstein, B.E. (2011). Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 12, 7-18.